| Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis ... - PR Newswire (press release) |
|
|
PR Newswire (press release)23 /PRNewswire/ -- Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease ... read more |